Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Cancer Biology & Therapy|June 14, 2013
Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trialJulia A Lawrence, Steven A Akman, Susan A Melin, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 6, 2003
Evaluation of vitamin D analogs as therapeutic agents for prostate cancerTai C Chen, Michael F Holick, Bal L Lokeshwar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancerGary G Schwartz, M Craig Hall, Diana Stindt, et al.
Journal of Cancer Research and Clinical Oncology|March 6, 2003
19-nor-1alpha,25-dihydroxyvitamin D(2) (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell linesIstván Molnár, Timothy Kute, Mark C Willingham, et al.
The Oncologist|October 4, 2011
Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexiaRony Dev, Egidio Del Fabbro, Gary G Schwartz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 7, 2002
The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089Carlos M Perez-Stable, Gary G Schwartz, Adan Farinas, et al.
Future Oncology (London, England)|August 25, 2017
County level incidence rates of chronic lymphocytic leukemia are associated with residential radon levelsS Cristina Oancea, Bradley C Rundquist, Isaac Simon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 18, 2015
Serum Calcium and Serum Albumin Are Biomarkers That Can Discriminate Malignant from Benign Pelvic MassesMichael G Kelly, Stuart S Winkler, Samuel S Lentz, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 25, 2007
Association between vitamin D status and physical performance: the InCHIANTI studyDenise K Houston, Matteo Cesari, Luigi Ferrucci, et al.
Carcinogenesis|January 20, 2004
The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin DMichael V Young, Gary G Schwartz, Lilin Wang, et al.
Pageof 9